If youve been using compounded semaglutide or are just starting your journey with medical weight loss, we can help you: Evaluate your options as the FDA rules evolve
Thus, GRs, their coregulators, and downstream systems may represent viable therapeutic targets to treat the stress side of OUD
To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps
Visualizing the Process and Further Learning Sometimes, reading about a process is one thing, but seeing it done can provide a new level of clarity
LIVER DISEASE INDICATION MASH Pathway FDA-Approved for Fatty Liver Disease (August 2025) On August 15, 2025 , the FDA approved Wegovy for treating MASH (metabolic dysfunction-associated steatohepatitis)a serious form of fatty liver disease affecting ~15 million Americans